日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Patritumab deruxtecan in HR(+)HER2(-) advanced breast cancer: a phase 2 trial

Patritumab deruxtecan治疗HR(+)HER2(-)晚期乳腺癌:一项II期试验

Pistilli, Barbara; Mosele, Fernanda; Corcos, Noemie; Pierotti, Livia; Pradat, Yoann; Le Bescond, Loic; Lacroix-Triki, Magali; Nachabeh, Ghada; Alfaro, Alexia; Catelain, Cyril; Job, Bastien; Mami-Chouaib, Fathia; Badel, Severine; Farace, Françoise; Oulhen, Marianne; Kannouche, Patricia; Tran, Diep T N; Droin, Nathalie; Vicier, Cecile; Frenel, Jean Sebastien; D'Hondt, Veronique; Dalenc, Florence; Bachelot, Thomas; Ducoulombier, Agnes; Benderra, Marc Antoine; Loirat, Delphine; Mayeur, Didier; Deluche, Elise; Deneuve, Jacqueline; Cheikh-Hussin, Rasha; Guyader, Pierre; Signolle, Nicolas; Godefroy, Karine; Talbot, Hugues; Vakalopoulou, Maria; Christodoulidis, Stergios; Bernard, Elsa; Koudou, Yves; Sporchia, Andrea; Suto, Fumitaka; Li, Lie; Sternberg, David W; Michiels, Stefan; André, Fabrice; Sellami, Dalila; Montagnac, Guillaume

Patritumab Deruxtecan (HER3-DXd; MK-1022) in Non-Small Cell Lung Cancer After Platinum-Based Chemotherapy and Immunotherapy

帕立妥单抗德鲁替康(HER3-DXd;MK-1022)用于铂类化疗和免疫治疗后的非小细胞肺癌

Steuer, Conor E; Hayashi, Hidetoshi; Su, Wu-Chou; Nishio, Makoto; Johnson, Melissa L; Kim, Dong-Wan; Massarelli, Erminia; Felip, Enriqueta; Gold, Kathryn A; Murakami, Haruyasu; Baik, Christina S; Kim, Sang-We; Smit, Egbert F; Fujimura, Masahiro; Fan, Pang-Dian; Truchon, Karine; Su, Xin; Sternberg, David W; Jänne, Pasi A

Exposure-Response Relationships in Patients with Non-Small-Cell Lung Cancer and Other Solid Tumors Treated with Patritumab Deruxtecan (HER3-DXd)

帕特妥单抗德鲁替康(HER3-DXd)治疗非小细胞肺癌和其他实体瘤患者的暴露-反应关系

Li, Li; Lee, Mark; Joshi, Rujuta; Xu, Yuan; Garcia, Ramon; Baron, Kyle; Anderson, Eric; Waterhouse, Tim; Sternberg, David; Shrestha, Pomy; Vaddady, Pavan; Abutarif, Malaz; Garimella, Tushar

HERTHENA-PanTumor01: a phase II study of patritumab deruxtecan (HER3-DXd) in previously treated advanced solid tumors

HERTHENA-PanTumor01:一项针对既往接受过治疗的晚期实体瘤患者的帕妥珠单抗德鲁替康(HER3-DXd)II期研究

Powles, Thomas; Bhatia, Aarti; Burtness, Barbara; Kogawa, Takahiro; Nishina, Tomohiro; Nakayama, Izuma; Fountzilas, Christos; Castillo, Dani R; McKean, Meredith; Meric-Bernstam, Funda; Colombo, Nicoletta; Smithy, James W; Fayette, Jérome; Chandra, Sunandana; Sternberg, David W; Jin, Fan; Sullivan, Kendall; Yueh, Sue; Clinthorne, Graham; Aguilo, Ariel E; Kudchadkar, Ragini; Hayashi, Hidetoshi

Real-World Treatment Patterns and Clinical Outcomes Among Patients with Metastatic or Unresectable EGFR-Mutated Non-Small Cell Lung Cancer Previously Treated with Osimertinib and Platinum-Based Chemotherapy

既往接受过奥希替尼和铂类化疗的转移性或不可切除的EGFR突变非小细胞肺癌患者的真实世界治疗模式和临床结果

Patel, Jyoti; Meng, Jie; Le, Hoa; Tanaka, Yoko; Phani, Sudarshan; Salas, Maribel; Wu, Chuntao; Sternberg, David; Esker, Stephen; Anderson, Jeffrey P; Crowley, Aaron; Zhou, Summera Q; Lieb, Camryn; Sun, Haiyan; Doan, Quan V; Santhanagopal, Anu; Reckamp, Karen L

HIV-Associated Genital Immune Biomarkers in the Female Sex Worker Population: A Pilot Study.

女性性工作者人群中 HIV 相关生殖器免疫生物标志物:一项试点研究

Capozzi Eleanor, Daniels Jason, Mohamed Hani, Mejia Fernando Cabezas, Sternberg David, Bouey Jennifer, Ghosh Mimi

HERTHENA-Lung01, a Phase II Trial of Patritumab Deruxtecan (HER3-DXd) in Epidermal Growth Factor Receptor-Mutated Non-Small-Cell Lung Cancer After Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy and Platinum-Based Chemotherapy

HERTHENA-Lung01,一项评估帕立妥单抗德鲁替康(HER3-DXd)治疗表皮生长因子受体酪氨酸激酶抑制剂和铂类化疗后表皮生长因子受体突变型非小细胞肺癌的II期临床试验

Yu, Helena A; Goto, Yasushi; Hayashi, Hidetoshi; Felip, Enriqueta; Chih-Hsin Yang, James; Reck, Martin; Yoh, Kiyotaka; Lee, Se-Hoon; Paz-Ares, Luis; Besse, Benjamin; Bironzo, Paolo; Kim, Dong-Wan; Johnson, Melissa L; Wu, Yi-Long; John, Thomas; Kao, Steven; Kozuki, Toshiyuki; Massarelli, Erminia; Patel, Jyoti; Smit, Egbert; Reckamp, Karen L; Dong, Qian; Shrestha, Pomy; Fan, Pang-Dian; Patel, Parul; Sporchia, Andrea; Sternberg, David W; Sellami, Dalila; Jänne, Pasi A

Patritumab Deruxtecan (HER3-DXd), a Human Epidermal Growth Factor Receptor 3-Directed Antibody-Drug Conjugate, in Patients With Previously Treated Human Epidermal Growth Factor Receptor 3-Expressing Metastatic Breast Cancer: A Multicenter, Phase I/II Trial

Patritumab Deruxtecan (HER3-DXd),一种靶向人表皮生长因子受体 3 的抗体药物偶联物,用于治疗既往接受过治疗的人表皮生长因子受体 3 表达转移性乳腺癌患者:一项多中心 I/II 期试验

Krop, Ian E; Masuda, Norikazu; Mukohara, Toru; Takahashi, Shunji; Nakayama, Takahiro; Inoue, Kenichi; Iwata, Hiroji; Yamamoto, Yutaka; Alvarez, Ricardo H; Toyama, Tatsuya; Takahashi, Masato; Osaki, Akihiko; Saji, Shigehira; Sagara, Yasuaki; O'Shaughnessy, Joyce; Ohwada, Shoichi; Koyama, Kumiko; Inoue, Tatsuya; Li, Li; Patel, Parul; Mostillo, Joseph; Tanaka, Yoshimi; Sternberg, David W; Sellami, Dalila; Yonemori, Kan

Efficacy and Safety of Patritumab Deruxtecan (HER3-DXd) in EGFR Inhibitor-Resistant, EGFR-Mutated Non-Small Cell Lung Cancer

Patritumab Deruxtecan (HER3-DXd) 在 EGFR 抑制剂耐药、EGFR 突变型非小细胞肺癌中的疗效和安全性

Jänne, Pasi A; Baik, Christina; Su, Wu-Chou; Johnson, Melissa L; Hayashi, Hidetoshi; Nishio, Makoto; Kim, Dong-Wan; Koczywas, Marianna; Gold, Kathryn A; Steuer, Conor E; Murakami, Haruyasu; Yang, James Chih-Hsin; Kim, Sang-We; Vigliotti, Michele; Shi, Rong; Qi, Zhenhao; Qiu, Yang; Zhao, Lihui; Sternberg, David; Yu, Channing; Yu, Helena A

Deciphering the landscape of phosphorylated HLA-II ligands

解读磷酸化 HLA-II 配体的概况

Marthe Solleder, Julien Racle, Philippe Guillaume, George Coukos, Michal Bassani-Sternberg, David Gfeller